20/06/2024 Healthcare
Nixipin-T Injection combines Cefepime with Tazobactam, synergizing their antibacterial properties to combat severe infections. Cefepime, a fourth-generation cephalosporin, offers broad-spectrum coverage against gram-positive and gram-negative bacteria. Tazobactam inhibits beta-lactamase enzymes, extending Cefepime's activity against resistant strains. Administered intravenously, Nixipin-T Injection is vital in hospital settings for treating complicated infections where multidrug resistance is a concern. It provides reliable therapy, ensuring effective treatment and favorable outcomes in critical care scenarios.Available in PCD Franchise for injectable range and third party manufacturing.
Nixipin-T Injection combines Cefepime with Tazobactam, synergizing their antibacterial properties to combat severe infections. Cefepime, a fourth-gene...
Piperacillin Tazobactam Injection I.P., marketed as Tamslar 4.5, combines piperacillin, an extended-spectrum penicillin antibiotic, with tazobactam, a...
Cefoperazone Tazobactam Injection, marketed as Ciflozone-TZ, combines a third-generation cephalosporin antibiotic with a beta-lactamase inhibitor. It ...
Nixipin-S Injection combines Cefepime and Sulbactam, offering a potent treatment for severe bacterial infections. Cefepime, a fourth-generation cephal...
More Details